NCT06577428View on ClinicalTrials.gov

A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

September 29, 2024

Study Completion Date

October 8, 2024

Conditions
Healthy
Interventions
DRUG

RAY1225

administered SC

Trial Locations (1)

Unknown

Guangdong Hospital of Chinese Medicine, Guanzhou

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06577428 - A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes | Biotech Hunter | Biotech Hunter